THE APEX TIMES
Patriots reportedly waive defensive tackle Jeremiah Pharms Jr. ahead of the 53-man deadline
New England is reportedly making its final roster cut down to 53 players without Jeremiah Pharms Jr., a defensive tackle whose time with the organization has stretched back to 2022.
The New England Patriots are reportedly waiving defensive tackle Jeremiah Pharms Jr. in advance of the NFL’s 53-man roster deadline. The move, first reported by Yahoo Sports, would remove Pharms Jr. from the Patriots’ active roster construction as the team finalizes who will carry roster status into the regular season.
According to the report, Pharms Jr.’s stay in Foxborough has “dates back to 2022,” framing this as part of a longer run within the organization rather than a brief preseason stop. The practical effect is roster math: the Patriots will “go down to 53 without Jeremiah Pharms Jr.”, meaning he will not be among the players retained for the final roster cut.
In the NFL, a waiver announcement before the 53-man deadline typically indicates a team has decided against keeping a player on its initial regular-season roster. The waiver process can still leave multiple paths for a player, including the chance that another team claims him or that he clears waivers and returns to a different roster category, but those outcomes are not established by this report.
The defensive tackle position is often among the most fluid spots during preseason final weeks, because teams balance run-defense needs, interior pressure plans, and depth contingencies. By removing Pharms Jr. from the 53, New England is effectively reallocating those roster slots, and the team’s remaining interior group becomes the immediate foundation for its early regular-season rotation.
This report does not provide additional detail about how Pharms Jr. is being evaluated, or whether the decision is tied to specific performance metrics, injury considerations, or scheme fit. With the evidence currently limited to the reporting described above, readers should treat the waiver as the key confirmed development while waiting for official team communications or league transaction records to clarify the full roster implication.
What to watch next is whether Pharms Jr. is claimed by another club or returns to the Patriots organization in a different capacity after clearing waivers, as well as how New England’s interior defensive depth reshapes for the season’s opening stretch. Those follow-on moves will determine how much value other teams see in his skill set and how quickly the Patriots fill the released roster spot.
Why It Matters
- A waiver before the 53-man deadline changes the immediate makeup of New England’s defensive depth and rotation plan.
- Whether Pharms Jr. is claimed or clears waivers can shift opportunities for both the player and other teams seeking interior help.
- Roster cuts in the trenches often foreshadow which players a team trusts to handle early-down run defense and interior pressure roles.
Key Facts
- Yahoo Sports reported the Patriots will waive defensive tackle Jeremiah Pharms Jr. ahead of the 53-man roster deadline.
- The report states Pharms Jr.’s time with the Patriots dates back to 2022.
- The report indicates New England will go down to 53 without Jeremiah Pharms Jr.
- The move occurs in the roster-cut window leading into the regular season.